# Study of Sulphoraphane in Chronic Kidney Disease

> **NCT05153174** · PHASE1 · COMPLETED · sponsor: **University of Rochester** · enrollment: 18 (actual)

## Conditions studied

- Chronic Kidney Disease stage3
- Chronic Kidney Disease stage4

## Interventions

- **DRUG:** Sulforaphane

## Key facts

- **NCT ID:** NCT05153174
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-02
- **Primary completion:** 2023-05-25
- **Final completion:** 2023-06-08
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-08-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05153174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05153174, "Study of Sulphoraphane in Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05153174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*